Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy

Clinica Chimica Acta

Volumn 411, Issue 17-18, 2010, Pages 1287-1290

  Zhou, Bin ^a   Rao, Li ^b   Peng, Ying ^b   Wang, Yanyun ^c   Chen, Yu ^b   Song, Yaping ^a   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Dilated cardiomyopathy; Genetic susceptibility; MicroRNAs; Polymorphism

Indexed keywords

ADENOSINE; CYTIDINE; GUANIDINE; MICRORNA; PRE MICRORNA; THYMIDINE; UNCLASSIFIED DRUG; PRIMER DNA;

ADULT; ALLELE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; CARDIOMYOPATHY, DILATED; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77954145580     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.05.010     Document Type: Article

References (43)

1. Towbin J.A., Bowles N.E. The failing heart. Nature 2002, 415:227-233.
2. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93:841-842.
3. Ichihara S., Yamada Y., Yokota M. Association of a G994→T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese. Circulation 1998, 98:1881-1885.
4. Small K.M., Wagoner L.E., Levin A.M., Kardia S.L., Liggett S.B. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002, 347:1135-1142.
5. Tang L.J., Chen X.F., Zhu M., et al. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population. Clin Biochem 2007, 40:1427-1430.
6. Zhou B., Rao L., Peng Y., Zhang Q., Zhang L. Epidermal growth factor receptor gene polymorphisms, R497K, but not (CA)n repeat, is associated with dilated cardiomyopathy. Clin Chim Acta 2009, 403:184-187.
7. Zhou B., Rao L., Peng Y., et al. Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy. BMC Med Genet 2009, 10:47.
8. Zhou B., Rao L., Li Y., et al. The association between dilated cardiomyopathy and RTN4 3'UTR insertion/deletion polymorphisms. Clin Chim Acta 2009, 400:21-24.
9. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
10. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
11. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
12. Krek A., Grun D., Poy M.N., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
13. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
14. Kumar M.S., Lu J., Mercer K.L., Golub T.R., Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007, 39:673-677.
15. Ikeda S., Kong S.W., Lu J., et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007, 31:367-373.
16. Duan R., Pak C., Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007, 16:1124-1131.
17. Tian T., Shu Y., Chen J., et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomark Prev 2009, 18:1183-1187.
18. Shen J., Ambrosone C.B., DiCioccio R.A., Odunsi K., Lele S.B., Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008, 29:1963-1966.
19. Xu T., Zhu Y., Wei Q.K., et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008, 29:2126-2131.
20. Hu Z., Chen J., Tian T., et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008, 118:2600-2608.
21. Hu Z., Liang J., Wang Z., et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009, 30:79-84.
22. Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
23. Barringhaus K.G., Zamore P.D. MicroRNAs: regulating a change of heart. Circulation 2009, 119:2217-2224.
24. Ghildiyal M., Zamore P.D. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009, 10:94-108.
25. Thum T., Catalucci D., Bauersachs J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 2008, 79:562-570.
26. van Rooij E., Olson E.N. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 2007, 117:2369-2376.
27. Olson E.N. Gene regulatory networks in the evolution and development of the heart. Science 2006, 313:1922-1927.
28. Cheng Y., Ji R., Yue J., et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am J Pathol 2007, 170:1831-1840.
29. van Rooij E., Sutherland L.B., Liu N., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006, 103:18255-18260.
30. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
31. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007, 100:416-424.
32. Care A., Catalucci D., Felicetti F., et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618.
33. Tatsuguchi M., Seok H.Y., Callis T.E., et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007, 42:1137-1141.
34. Zhao Y., Ransom J.F., Li A., et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007, 129:303-317.
35. Yang B., Lin H., Xiao J., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13:486-491.
36. Latronico M.V., Catalucci D., Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res 2007, 101:1225-1236.
37. Thum T., Galuppo P., Wolf C., et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007, 116:258-267.
38. Yang B., Lu Y., Wang Z. Control of cardiac excitability by microRNAs. Cardiovasc Res 2008, 79:571-580.
39. Latronico M.V., Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009, 6:419-429.
40. Sucharov C., Bristow M.R., Port J.D. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol 2008, 45:185-192.
41. da Costa Martins P.A., Bourajjaj M., Gladka M., et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 2008, 118:1567-1576.
42. Chen J.F., Murchison E.P., Tang R., et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA 2008, 105:2111-2116.
43. Xu J., Hu Z., Xu Z., et al. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat 2009, 30:1231-1236.